Detalhe da pesquisa
1.
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.
Hepatology
; 74(6): 3269-3283, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129689
2.
Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom.
Clin Gastroenterol Hepatol
; 17(7): 1379-1387.e3, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30557739
3.
Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus.
Liver Int
; 39(5): 967-975, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30735608
4.
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.
Lancet
; 389(10074): 1114-1123, 2017 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28187915
5.
Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Dig Dis
; 35(3): 267-274, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28249258
6.
What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?
Dig Dis
; 35(4): 359-366, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28468009
7.
Bezafibrate in Primary Biliary Cholangitis.
N Engl J Med
; 379(10): 984, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30207645
8.
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.
BMC Gastroenterol
; 16(1): 71, 2016 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27431238
9.
Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
Dig Dis Sci
; 61(10): 3037-3044, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27435324
10.
Drug treatment of pruritus in liver diseases.
Clin Med (Lond)
; 15(4): 351-7, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26407384
11.
Pulmonary complications of treatment with pegylated interferon for hepatitis C infection-two case reports.
Ann Hepatol
; 12(4): 629-33, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23813142
12.
Modern management of acute non-variceal upper gastrointestinal bleeding.
Postgrad Med J
; 89(1056): 591-8, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23924686
13.
Advances in coeliac disease.
Curr Opin Gastroenterol
; 28(2): 104-12, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22123644
14.
Factors predicting 30-day mortality after ERCP in patients with inoperable malignant hilar biliary obstruction: a single tertiary referral centre experience and systematic review.
BMJ Open Gastroenterol
; 9(1)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301232
15.
Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?
Can J Gastroenterol Hepatol
; 2022: 3618090, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523650
16.
Intraductal fully covered self-expanding metal stents in the management of post-liver transplant anastomotic strictures: a UK wide experience.
Therap Adv Gastroenterol
; 15: 17562848221122473, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36187366
17.
Diagnosis and management of IgG4-related disease.
Frontline Gastroenterol
; 10(3): 275-283, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31288262
18.
Update on the optimisation of endoscopic retrograde cholangiography (ERC) in patients with primary sclerosing cholangitis.
Frontline Gastroenterol
; 15(1): 74-83, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38487565
19.
The 4-hour rule: preventing crowding in the emergency department.
Ann Emerg Med
; 60(1): 133; author reply 133-4, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22720853
20.
Novel bile acid therapeutics for the treatment of chronic liver diseases.
Therap Adv Gastroenterol
; 9(3): 376-91, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27134666